We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comparison of Gefitinib Versus Erlotinib in Patients With Nonsmall Cell Lung Cancer Who Failed Previous Chemotherapy.
- Authors
Seung Tae Kim; Jeeyun Lee; Jeong-hoon Kim; Young-Woong Won; Jong-mu Sun; Jina Yun; Yeon Hee Park; Jin Seok Ahn; Keunchil Park; Myung-Ju Ahn
- Abstract
The article provides information on a study which determined the clinical outcomes between gefitinib-treated and erlotinib-treated patients with metastatic or recurrent nonsmall cell lung cancer (NSCLC). Study population were patients with metastatic or recurrent NSCLC who had progressed on poor therapies and given gefitinib or erlotinib therapy between January 2006 and December 2008. A discussion on the findings is offered. Researchers observed a similar antitumor benefits of gefitinib and erlotinib in terms of response rate and overall survival.
- Subjects
ANTINEOPLASTIC agents; HEALTH outcome assessment; LUNG cancer treatment; CANCER chemotherapy; CANCER research
- Publication
Cancer (0008543X), 2010, Vol 116, Issue 12, p3025
- ISSN
0008-543X
- Publication type
Article
- DOI
10.1002/cncr.25130